Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy
在接受伊马替尼一线治疗的慢性粒细胞白血病患者中,获得更深层次的分子学缓解与更好的临床疗效相关。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2013.095158
Etienne, Gabriel; Dulucq, Stéphanie; Nicolini, Franck-Emmanuel; Morisset, Stéphane; Fort, Marie-Pierre; Schmitt, Anna; Etienne, Madeleine; Hayette, Sandrine; Lippert, Eric; Bureau, Caroline; Tigaud, Isabelle; Adiko, Didier; Marit, Gérald; Reiffers, Josy; Mahon, François-Xavier